跳至主要内容
临床试验/IRCT2015102624713N1
IRCT2015102624713N1已完成2 期

Effectiveness of oral pentoxifylline for the prevention of contrast nephropathy in CKD patients undergoing coronary angiography

Vice chancellor for research,Zahedan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Inclusion criteria of ckd patients with angiography and cardiac catheterization indication include:Age greater than 18 and less than 75 years,Patient satisfaction for the study
  • Exclusion criteria include : problems in patients follow up, treatment with theophylline, furosemide, mannitol or dopamine in last one month,use of Nonsteroidal anti-inflammatory drugs, aminoglycosides, N-acetylcysteine drugs,Renal failure patients with serum creatinine equal to or less than 1.5 mg per deciliter, Patients with an allergy to contrast material, Patients with Multiple myeloma, Pulmonary edema, Uncontrolled hypertension, patient required emergency angiography,
  • diagnostic use of radiocontrast material for patient in the last 2 months of other diagnostic reasons, congestive heart failure,pregnancy, lactation
  • Sensitivity to the NAC or pentoxifylline

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research,Zahedan University of Medical Sciences

相似试验